Work

Actionability of genomic alterations in the Molecular Screening and Therapeutics (MoST) program in New Zealand (NZ) depending on residence in NZ or Australia.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e13763

Authors: Yifei Zhu, Frank Po-Yen Lin, Jane Yeojeong So, Eileen Wonkyoung Oh, Sarah Philipsen, David Morgan Thomas, John P. Grady, Benjamin James Lawrence, Michelle K. Wilson

Institutions: Health New Zealand, Garvan Institute of Medical Research, Auckland City Hospital, Omico, University of Auckland

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410811644

FWCI:

Cites:

Cited by:

Related to: 10